心肌桥相关专利技术进展

Advances on patent technologies associated with myocardial bridge in China

心肌桥近段易合并冠状动脉粥样硬化,可能导致心肌缺血,进而诱发心绞痛、急性冠脉综合征、左心功能异常、晕厥甚至心源性猝死等,但目前仍缺乏对其机制的研究以及可靠的数据支持。近年来,人们开发了心肌桥模拟装置在体外模拟并研究心肌桥的病理生理作用。综述近年来中国在冠状动脉及心泵的模拟装置,心肌桥模拟及图像获取设备,心肌桥的中药、脉冲电场消融及支架置入设备方面的专利技术进展。

The proximal segment of myocardial bridge is prone to coronary atherosclerosis.This may lead to myocardial ischemia,which can result in angina,acute coronary syndrome(ACS),left ventricular dysfunction,syncope and even sudden cardiac death.However,there is lack of mechanisms and robust data.This article reviews the recent advances of patented technology in China,including coronary artery and heart pump simulation devices,myocardial bridge simulation and image acquisition equipment,traditional Chinese medicine,pulsed field ablation and stent implantation equipment of myocardial bridge.